Eli Lilly has introduced a new, more affordable form of its weight loss drug, Zepbound, offering single-dose vials at nearly half the usual price. The move makes the medication more accessible to uninsured and Medicare patients. It also aims to expand the drug's supply in response to rising demand and combat the spread of counterfeit versions. The vials are available directly through Lilly's website, offering a transparent pricing model by bypassing third-party supply chains. This initiative also seeks to ensure patients receive genuine, FDA-approved treatments.
Category
🗞
NewsTranscript
00:00It's Benzinga, and here's what's on the block.
00:02Eli Lilly has introduced a new, more affordable form of its weight loss drug, Zepfound, offering
00:07single-dose vials at nearly half the usual price.
00:10The move makes the medication more accessible to uninsured and Medicare patients.
00:14It also aims to expand the drug's supply in response to rising demand and combat the
00:18spread of counterfeit versions.
00:20The vials are available directly through Lilly's website, offering a transparent pricing model
00:24by bypassing third-party supply chains.
00:27This initiative also seeks to ensure patients receive genuine, FDA-approved treatments.
00:32For all things money, visit Benzinga.com.